1Juan Zhang~1 Jin-Kun Zhang~2 Shao-Hong Zhuo~3 Hai-Bin Chen~2 1 Clinical Laboratory,The First Affiliated Hospital of Shantou University Medical College,Shantou 515041,Guangdong Province,China2 Cancer Pathology Laboratory,Shantou University Medical College,Shantou 515031,Guangdong Province,China3 Department of Gastroenterology,Third Municipal Hospital of Shantou,Shantou 515073,Guangdong Province,China.Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells[J].World Journal of Gastroenterology,2001,7(5):690-694. 被引量：26
7[1]Mazzaferro V,Regalia E,Doci R,Andreola S,Pulvirenti A,Bozzetti F,Montalto F,Ammatuna M,Morabito A,Gennari L.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med 1996; 334:693-699
8[2]A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire.N Engl J Med 1995; 332:1256-1261
9[3]Bruix J,Llovet JM,Castells A,Montana X,Bru C,Ayuso MC,Vilana R,Rodes J.Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma:results of a randomized,controlled trial in a single institution.Hepatology 1998; 27:1578-1583
6Wan-Ping Chen, Xin He, Qi-Fa Ye and Ke Li Institute of Organ Transplantation, Third Xiangya Hospital, Xiangya Medical College, Central South University, Changsha 410013, China, and Institute of Clinical Pharmacology, Xiangya Medical College, Central South University, Changsha 410078, China.Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):391-395. 被引量：2
